ADC Therapeutics Faces Competitive Oncology Market But Analyst Sees 100% Upside - Here's Why - ADC Therapeutics ( NYSE:ADCT )

5 days ago

ADC Therapeutics Faces Competitive Oncology Market But Analyst Sees 100% Upside - Here's Why Stephens analyst has initiated coverage on ADC Therapeutics SA ADCT, a commercial-stage oncology-focused biotechnology company developing antibody-drug conjugates ( ADCs ) for patients with hematological ...

Ticker	Sentiment	Impact
ADCT	Somewhat Bullish	45 %